ALAlcon ALC · NYSE
$74.90 -2.16% (-$1.65)
- Market cap
- $37.0B
- Enterprise value
- $40.9B
- P/E
- 57.9x
- Forward P/E
- 21.7x
- PEG
- -
- P/S
- 3.4x
- P/FCF
- 22.0x
- EV/EBITDA
- 23.3x
- ROIC
- 2.8%
- Gross margin
- 56.5%
- Net margin
- 5.9%
- Dividend yield
- 0.47%
- Payout ratio
- 27.2%
- Net debt/EBITDA
- 2.2x
- Beta
- 0.72
- Free float
- 99.7%
About the company
Alcon Inc. (ALC) is a global company operating in the field of ophthalmology and eye care. The company specializes in the development, manufacturing, and distribution of a wide range of eye products, including pharmaceuticals, medical devices, and surgical instruments. Alcon focuses on various eye conditions and issues, including cataracts, glaucoma, macular degeneration, and other eye diseases. Its products and technologies are used in both diagnosis and treatment of eye conditions, helping to improve vision and the quality of life for patients. Alcon has a long history and is recognized as a leader in the field of ophthalmology. The company continually strives to innovate and develop new technologies and treatment approaches to enhance eye care worldwide. Alcon Inc. (ALC) shares may be an attractive investment opportunity for investors interested in the healthcare sector and seeking an investment in a company specializing in ophthalmology and eye care.
Sector
Healthcare
Industry
Medical - Specialties
CEO
David J. Endicott
Employees
25,000
Headquarters
Geneva
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 43% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 16 USD is left as free cash.
- What to watch: It earns only 2.8 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number